Login
From:
STAT
(Uncensored)
subscribe
STAT+: FDA delivers split decision on GSK’s blood cancer drug Blenrep, approving its use in some cases
https://www.statnews.com/2025/10/23/fda-approves-blenrep-gsk-drug-multiple-myeloma/?utm_campaign=rss
links
backlinks
Tagged with:
biotech
pharmaceuticals
drug development
stat+
The FDA delivers a split decision on GSK’s blood cancer drug Blenrep, approving its use in some cases.
Roast topics
Find topics
Roast it!
Roast topics
Find topics
Find it!
Roast topics
Find topics
Find it!
